GARUX
Price
$11.41
Change
+$0.04 (+0.35%)
Updated
Jun 2 closing price
Net Assets
6.15B
MSTVX
Price
$10.70
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
256.49M
Interact to see
Advertisement

GARUX vs MSTVX

Header iconGARUX vs MSTVX Comparison
Open Charts GARUX vs MSTVXBanner chart's image
GARUX vs MSTVX Comparison Chart in %
View a ticker or compare two or three
VS
GARUX vs. MSTVX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GARUX is a StrongBuy and MSTVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GARUX has more cash in the bank: 6.15B vs. MSTVX (256M). MSTVX pays higher dividends than GARUX: MSTVX (3.38) vs GARUX (0.46). GARUX was incepted earlier than MSTVX: GARUX (11 years) vs MSTVX (8 years). MSTVX (1.55) is less costly to investors than GARUX (0.79). MSTVX is a more actively managed with annual turnover of: 213.00 vs. GARUX (134.00). MSTVX has a lower initial minimum investment than GARUX: MSTVX (0) vs GARUX (5000000). GARUX annual gain was more profitable for investors over the last year : 12.91 vs. MSTVX (4.29). GARUX return over 5 years is better than : 17.75 vs. MSTVX (13.15).
GARUXMSTVXGARUX / MSTVX
Total Expense Ratio0.731.3953%
Annual Report Gross Expense Ratio0.791.5551%
Fund Existence11 years8 years-
Gain YTD6.3610.753844%
Front LoadN/AN/A-
Min. Initial Investment50000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.15B256M2,402%
Annual Yield % from dividends0.463.3814%
Returns for 1 year12.914.29301%
Returns for 3 years29.4821.50137%
Returns for 5 years17.7513.15135%
Returns for 10 years41.96N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCINX13.59N/A
N/A
VALIC Company I International Growth
FSMEX43.98N/A
N/A
Fidelity Select Medical Tech and Devcs
ISFIX20.51N/A
N/A
VY® Columbia Contrarian Core I
FRBRX189.71N/A
N/A
Franklin Biotechnology Discovery R6
JHEQX34.71N/A
N/A
JPMorgan Hedged Equity I